As far as the studies that have explored the expression levels of HIF-2α are concerned, it has been reported that in a cohort of 33 AML cases, 10 displayed higher levels of HIF-2α compared to normal CD34 + cells [60]. This evidence concerns the gene EPAS1 and acute myeloid leukemia.